GeneBio Systems
Recombinant Human PSMA Protein (His Tag)
Recombinant Human PSMA Protein (His Tag)
SKU:PKSH033667
Couldn't load pickup availability
Size: 50μg
Storage: Store at < -20°C, stable for 6 months. Please minimize freeze-thaw cycles.
Shipping: This product is provided as liquid. It is shipped at frozen temperature with blue ice/gel packs. Upon receipt, store it immediately at < - 20°C.
Exp date: 12 months
Category ID_II: Recombinant Proteins
Category ID_III: Others
Abbreviation: PSMA
Target Synonym: Cell growth-inhibiting gene 27 protein;FGCP;FOLH;FOLH1;Folate hydrolase 1;GCP2;GCPII;Glutamate carboxypeptidase 2;Mgcp;NAALAD1;NAALADase I;NAALAdase;PSM;PSMA;mGCP
Research Areas: Signal Transduction;Cancer;metabolism;
Conjugation:
Target Species: Human
Expression Host: HEK293 Cells
Application:
Fusion tag: N-His
UNIProt ID: Q04609
Accession: Q04609
Background: Glutamate carboxypeptidase 2, also known as FOLH1, PSMA, belongs to the M28B subfamily and the peptidase M28 family. It is highly expressed in prostate epithelium and can be detected in urinary bladder, kidney, testis, ovary, fallopian tube, breast, adrenal gland, liver, esophagus, stomach, small intestine, colon and brain (at protein level). PSMA is used as a diagnostic and prognostic indicator of prostate cancer, and as a possible marker for various neurological disorders such as schizophrenia, Alzheimer disease and Huntington disease. It has both folate hydrolase and N-acetylated-alpha-linked-acidic dipeptidase (NAALADase) activity and has a preference for tri-alpha-glutamate peptides. PSMA involves in prostate tumor progression and also exhibits a dipeptidyl-peptidase IV type activity. In vitro, PSMA cleaves Gly-Pro-AMC. PSMA is stable at pH greater than 6.5.
Concentration:
Activity: Not validated for activity
Sequence: Lys44-Ala750
Purity: > 95 % as determined by reducing SDS-PAGE.
Formulation: Supplied as a 0.2 μm filtered solution of 20mM MES, 150mM NaCl, 5% Trehalose, pH 5.5.
Reconstitution: Not Applicable
Endotoxin: < 1.0 EU per μg of the protein as determined by the LAL method.
Calculated MW: 80.6 kDa
ObservedMW: 90-120 kDa
